GE Healthcare buys bioprocessing startup Puridify
GE Healthcare has acquired Puridify, a bioprocessing startup that is developing a nanofibre-based platform purification technology for biopharmaceutical production. Puridify’s technology will improve productivity in the process development phase and small-scale manufacturing of a variety of biopharmaceutical applications. GE Healthcare will help to commercialise Puridify’s FibroSelect product as part of its existing range of bioprocess purification products. Puridify’s team of 17 will continue to work at its research hub in Stevenage.